Novel benzamide analogs as nematicides against root-knot nematodes

Overview

Root-knot nematodes (Meloidogyne spp.) are among the most damaging crop parasites worldwide, causing substantial yield losses. This project focuses on designing and synthesizing novel benzamide analogs as nematicides, building on the proven mitochondrial complex II inhibition mechanism of commercial benzamide nematicides like Fluopyram. The research explores two complementary strategies: attaching mitochondria-targeting lipophilic cations (such as triphenylphosphonium salts) to concentrate active compounds at the site of action, and molecular hybridization of benzamides with other electron transport chain inhibitor pharmacophores to boost selectivity and potency.

Technical specifications

• Scaffold design: Modifications focused on aromatic ring B while preserving the essential benzamide moiety (ring A)
• Lipocation strategy: Alkyl chains terminated with lipophilic cations (e.g., triphenylphosphonium salts) designed to accumulate within nematode mitochondria
• Molecular hybridization: Hybrid compounds combining benzamides with N-heterocyclic rings linked to electron transport chain inhibition
• Bioassay platform: Adapted IR-based motility assay using C. elegans as a nematode model, optimized for increased sensitivity
• Validation pipeline: Screening against C. elegans followed by in vitro and in vivo testing against Meloidogyne incognita for the most promising candidates
• Synthetic scope: Ester, thioamide, selenoamide, triazole, sulfonamide, and urea bioisosteres previously explored to define structure-activity relationships

Technology readiness level

The project is at an early-to-mid research stage. Prior work has established that the benzamide moiety is essential for nematicide activity and has screened several bioisosteres. The current phase focuses on synthesizing new analogs incorporating lipophilic cations and hybrid pharmacophores, with synthesis expected to take 6–8 months, followed by approximately 6 months of biological evaluation against C. elegans and Meloidogyne incognita. The research is supported by established collaborators and validated biological protocols, positioning it for translational development toward agricultural applications.